However, in the comprehensive assessment of WA1 and Beta mRNA vaccination in the K18-hACE2 transgenic mice with homologous and heterologous infection (WA1, Alpha, Beta, Delta), a high dose of vaccination provided protection with no evidence of breakthrough of infectious virus in nasal washes, lungs or brain [32]. Here, KRT18 is linked to infection.